kw 2189 has been researched along with Kidney Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bowden, C; Figlin, R; Horak, I; Kremer, A; Petrylak, D; Pincus, R; Sartor, O; Small, EJ; Vaughn, DJ | 1 |
1 trial(s) available for kw 2189 and Kidney Neoplasms
| Article | Year |
|---|---|
A phase II pilot study of KW-2189 in patients with advanced renal cell carcinoma.
Topics: Antibiotics, Antineoplastic; Carcinoma, Renal Cell; Duocarmycins; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Pilot Projects; Pyrrolidinones | 2000 |